Novel Bendroflumethiazide formulations and method

Details Novel Bendroflumethiazide formulations and method Novel Bendroflumethiazide formulations and method

1981-07-13

1982-04-27

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

424246, 424362, A61K 920, A61K 3179, A61K 4700

Patent

active

043270808

ABSTRACT:
New bendroflumethiazide formulations in solid form are provided which are characterized by excellent disintegration and dissolution capabilities even after long periods of storage. The new bendroflumethiazide formulations, for example, in the form of tablets, are formed of one or more excipients and a dry granulation containing one or more fillers, such as lactose and starch, and a preformed partial coprecipitate of bendroflumethiazide and a wetting agent therefor, such as polyvinyl pyrrolidone which converts the bendroflumethiazide into a more hydrophilic form.

REFERENCES:
patent: 2820741 (1958-01-01), Endicott et al.
patent: 2918411 (1959-12-01), Hill
patent: 3102845 (1963-09-01), Fennell
patent: 3136692 (1964-06-01), Bandelin
patent: 3257277 (1966-06-01), Hwang
patent: 3265573 (1966-08-01), Goldberg
patent: 3632778 (1972-01-01), Sheth et al.
patent: 3673163 (1972-06-01), Walkling
patent: 3920809 (1975-11-01), Thakkar
patent: 3932615 (1976-01-01), Ito et al.
patent: 4143129 (1979-03-01), Marsden
patent: 4195078 (1980-03-01), Conine
Rubenstein, M. H., Drug Dev. Ind. Pharm. 1977, 3(5), 439-450, The Effect of Excipient Solubility on the in vitro and in vivo Properties of Bendrofluazide Tablets 5 mg.
Rubenstein, M. H., Pharm. Acta. Helv. 1977, 52(1-2), 5-10, The Effect of Granule Size on the in vitro and in vivo Properties of Bendrofluazide Tablets 5 mg.
Beermann, B., Clin. Pharmacol. Ther. 1977, 22(4), 385-388.
Beermann, B., Acta. Med. Scand. 1978, 204(4), 291-293.
Corrigan, Ol et al., Int. J. Pharm. 1979, 4(1), 67-74.

Affiliated with

Also associated with

Rating

Novel Bendroflumethiazide formulations and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel Bendroflumethiazide formulations and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel Bendroflumethiazide formulations and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2197489